Foundation Medicine's approach broadly examines the tumour genome
The Foundation Medicine comprehensive genomic profiling approach leverages next-generation sequencing (NGS) technology to examine regions of the tumour genome that other tests miss.1–12 Comprehensive genomic profiling detects the four main classes of genomic alterations – base substitutions, insertions or deletions, copy number alterations and gene rearrangements – in a comprehensive set of cancer-relevant genes, and reports tumour mutational burden (TMB) and microsatellite instability (MSI).*1–6
What makes comprehensive genomic profiling different?
Multigene hotspot NGS tests
Comprehensive genomic profiling
Clear, in-depth reports support clinical decision-making
Our clear, in-depth report supports clinical decision-making by providing insights on the patient’s genomic profile as well as associated targeted therapies, immunotherapies and relevant clinical trials. The report also highlights important disease-relevant genes with no reportable alterations identified and genomic alterations associated with potential resistance to therapy to help rule out potentially ineffective treatment.13